Measuring the Trend of Use of Targeted Therapy and Economic Evaluation of Gefitinib for Advanced Non-Small Cell Lung Cancer (Nsclc) in Singapore

Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.116
https://www.valueinhealthjournal.com/article/S1098-3015(14)02046-4/fulltext
Section Title : Disease-Specific Studies
Section Order : 2121
First Page : A737
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02046-4&doi=10.1016/j.jval.2014.08.116
HEOR Topics :
Tags :
Regions :